Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   155,668    

Indirect Shares

   6,673      
Direct Value   $4,979,580    

Indirect Value

   $0      
Total Shares   162,341      
Total Value   $4,979,580      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $753,170 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $753,170
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2023-06-02 40,493 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MYGN Myriad Genetics Inc Director   –       •      –    2023-06-02 4 AS $23.01 $198,760 D/D (8,638) 40,493 0 %
MYGN Myriad Genetics Inc Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 15,151 49,131 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2022-06-06 4 AS $19.25 $123,673 D/D (6,424) 33,980 0 %
MYGN Myriad Genetics Inc Director   –       •      –    2022-06-02 4 A $0.00 $0 D/D 17,275 40,404 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2021-06-17 4 AS $30.52 $95,795 D/D (3,139) 23,129 0 %
MYGN Myriad Genetics Inc Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 12,848 26,268 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2021-05-28 4 AS $28.99 $207,023 D/D (7,142) 13,420 0 %
MYGN Myriad Genetics Inc Director   –       •      –    2021-05-27 4 D $0.00 $0 D/D (15,889) 20,562 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2020-12-04 4 A $0.00 $0 D/D 15,889 36,451 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2020-05-27 4 A $0.00 $0 D/D 20,562 20,562 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-04-30 4 A $68.78 $12,106 D/D 176 47,686 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-04-01 4 AS $89.00 $1,199,097 D/D (13,473) 47,510 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-27 4 AS $90.00 $9,000 D/D (100) 60,983 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-22 4 D $88.05 $316,804 D/D (3,598) 61,083 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-15 4 D $94.53 $683,168 D/D (7,227) 55,311 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-15 4 A $0.00 $0 D/D 9,370 64,681 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-01 4 D $94.76 $86,421 D/D (912) 62,538 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 12,205 63,450 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-10-31 4 A $68.78 $12,037 D/D 175 51,245 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-06-22 4 AS $99.00 $990,005 D/D (10,000) 51,070 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-06-04 4 D $92.07 $157,532 D/D (1,711) 61,070 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-04-30 4 A $68.78 $11,487 D/D 167 62,781 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-04-23 4 AS $82.15 $908,497 D/D (11,059) 62,543 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-22 4/A D $81.36 $292,733 D/D (3,598) 73,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-22 4 D $81.36 $291,513 D/D (3,583) 73,602 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us